Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

GLIMEPIRIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Glimepiride, and when can generics launch?

Glimepiride is a drug marketed by Teva, Carlsbad, Indoco Remedies, Micro Labs Ltd India, Mylan, Hikma Pharms, Aurobindo Pharma Ltd, Ranbaxy, Prinston Inc, Corepharma, Ranbaxy Labs Ltd, Watson Labs, Accord Hlthcare, Dr Reddys Labs Ltd, Actavis Labs Fl Inc, and Invagen Pharms. and is included in seventeen NDAs.

The generic ingredient in GLIMEPIRIDE is glimepiride. There are fourteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the glimepiride profile page.

Summary for Tradename: GLIMEPIRIDE

Patents:0
Applicants:16
NDAs:17
Suppliers / Packagers: see list42
Bulk Api Vendors: see list78
Clinical Trials: see list69
Patent Applications: see list5,630
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GLIMEPIRIDE at DailyMed

Pharmacology for Tradename: GLIMEPIRIDE

Ingredient-typeSulfonylurea Compounds
Drug ClassSulfonylurea
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
GLIMEPIRIDE
glimepiride
TABLET;ORAL078181-001Aug 23, 2007ABRXNoNo► Subscribe► Subscribe
Corepharma
GLIMEPIRIDE
glimepiride
TABLET;ORAL077274-002Oct 6, 2005DISCNNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
GLIMEPIRIDE
glimepiride
TABLET;ORAL077091-003Oct 6, 2005ABRXNoNo► Subscribe► Subscribe
Mylan
GLIMEPIRIDE
glimepiride
TABLET;ORAL077486-002Feb 10, 2006DISCNNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
GLIMEPIRIDE
glimepiride
TABLET;ORAL076995-001Apr 27, 2010DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot